SIM Acquisition Corp. I
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsSIM Acquisition Corp. I is a blank check company focused on healthcare industry business combinations, with no target selected yet.
What they do
SIM Acquisition Corp. I is a Cayman Islands exempted company formed to effect a business combination, focusing on companies in the healthcare industry. It completed its IPO in July 2024, raising $230 million in gross proceeds, and holds those funds in a trust account. The company has not selected any business combination target.
Revenue drivers
- Interest income on trust account — The company earns interest on the $230 million held in the trust account, which is its primary source of income.
Recent performance
For fiscal year 2025, the company reported net income of $8.8 million, up from $4.7 million in 2024. Operating cash flow was negative $631,658 in 2025, improving from negative $843,935 in 2024. As of June 30, 2026, total assets were $6.4 million, total liabilities $1.1 million, and cash and equivalents were $260,436, with negative shareholder equity of $693,323.
Strategy
The company intends to use cash from the IPO and private placement, plus proceeds from future share sales, debt, or securities issued to target owners, to complete a business combination. It focuses on healthcare companies. Management is actively searching for a target, and the deadline for completing a business combination is July 12, 2027 (36 months from the IPO close).
Risks
- Failure to complete business combination — If no business combination is completed by July 12, 2027, the company will redeem all public shares and wind down.
- Dilution from share issuance — Issuing additional shares in a business combination could significantly dilute the equity interest of public investors.
- Debt financing risks — Incurring debt could lead to default, acceleration of obligations, or restrictions on financial flexibility.
- Key executive and board changes — The company underwent a sponsor acquisition in January 2026, leading to the resignation of former executives and the appointment of new leadership.
Outlook
Management continues to evaluate potential target companies in the healthcare industry. The company has until July 12, 2027, to complete a business combination, with an extension period subject to shareholder approval. If the deadline is missed, the company will redeem public shares and cease operations.